1210419-26-3 Usage
General Description
Methyl 6-bromo-5-fluoropyridine-2-carboxylate, also known as 6-bromo-5-fluoro-2-pyridinecarboxylic acid methyl ester, is a chemical compound with the molecular formula C8H6BrFNO2. It is a pyridine derivative with a bromine atom at the 6th carbon, a fluorine atom at the 5th carbon, and a carboxymethyl group at the 2nd carbon in the pyridine ring. Methyl 6-bromo-5-fluoropyridine-2-carboxylate is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds due to its versatile reactivity and functional groups. Additionally, it can serve as a building block for the preparation of various heterocyclic compounds and can be used in the development of new materials and analytical standards.
Check Digit Verification of cas no
The CAS Registry Mumber 1210419-26-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,0,4,1 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1210419-26:
(9*1)+(8*2)+(7*1)+(6*0)+(5*4)+(4*1)+(3*9)+(2*2)+(1*6)=93
93 % 10 = 3
So 1210419-26-3 is a valid CAS Registry Number.
1210419-26-3Relevant articles and documents
CHEMICAL COMPOUNDS
-
, (2022/01/23)
-
N-(3-PYRIDYL) BIARYLAMIDES AS KINASE INHIBITORS
-
, (2014/03/25)
The present invention provides a compound of formula (I): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula (I), and pharmaceutical compositions comprising such compounds.
CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS
-
, (2012/02/01)
The present invention provides a compound of Formula (I): and pharmaceutically acceptable salts thereof, as further described herein. Also provided are formulations comprising compounds of formula I, and a method to use such compounds for treating a disease or condition mediated by Provirus Integration of Maloney Maloney Kinase (PIM Kinase), GSK3, PKC, KDR, PDGFRa, FGFR3, FLT3, or cABL.
